Chardan Capital restated their buy rating on shares of Kodiak AI (NASDAQ:KDK – Free Report) in a research report released on Wednesday,Benzinga reports. They currently have a $12.00 price target on the stock. A number of other equities analysts also recently commented on KDK. Wall Street Zen downgraded shares of Kodiak AI from a “sell” […]

Chardan Capital restated their buy rating on shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Free Report) in a research report released on Monday,Benzinga reports. They currently have a $115.00 price target on the biotechnology company’s stock. ARWR has been the topic of several other research reports. B. Riley Financial lifted their target price on Arrowhead Pharmaceuticals […]